Z-0880-2026 Class II Ongoing

Recalled by Accriva Diagnostics, Inc. — San Diego, CA

FDA device recall Z-0880-2026 was initiated by Accriva Diagnostics, Inc. on Nov 5, 2025 and is designated Class II. Reason for recall: Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling. The recall status is ongoing. Affected quantity: 20250.

Recall details

Product Type
Devices
Report Date
Dec 10, 2025
Initiation Date
Nov 5, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20250

Product description

Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation System

Reason for recall

Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.

Distribution pattern

Worldwide - US Nationwide distribution including in the states of OH, IL, NY, GA, CA, IN, NJ, TX, KS, NE, FL, SC, MO, WV, WA, MI, CO, TN, PA, UT, LA, MT, NC, KY, TX and the countries of CA.

Code information

UDI-DI: 10711234103081. Lot: E5JLR132. Expiration: 08-31-2026

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0880-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0880-2026. Report a data issue: hello@regdatalab.com.